Breaking News Instant updates and real-time market news.

GNMX

Aevi Genomics Medicine

$2.21

-3.23 (-59.38%)

06:30
03/21/17
03/21
06:30
03/21/17
06:30

Aevi Genomics Medicine downgraded to Hold from Buy at Jefferies

Jefferies analyst Matthew Andrews downgraded Aevi Genomics Medicine to Hold after AEVI-001 didn't achieve significance on primary endpoint in ADHD. The analyst sees shares being range-bound and cut his price target for the stock to $2.50 from $10.

  • 21

    Mar

GNMX Aevi Genomics Medicine
$2.21

-3.23 (-59.38%)

01/05/17
JEFF
01/05/17
NO CHANGE
JEFF
Celgene, Alkermes among Jefferies' top 2017 Biotech picks
Jefferies' Biotechnology equity research team laid out their top picks for 2017. Following a volatile two years, the biotech space seeks to achieve "greater equilibrium" in 2017, the analysts write in a research note. They cite increasing competition, slowing volumes, and ramping payer leverage as reasons to remain selective when picking stocks this year and beyond. Among large-caps, Jefferies likes Celgene (CELG) for its "best-in-class growth" and sees limited downside in Gilead (GILD) shares. In the mid-cap space, the firm favors Alkermes (ALKS) given the prospects for Vivitrol and Aristada and a "strong" neurology pipeline as well as Vertex (VRTX). Jefferies' top small-cap picks include Aevi Genomics Medicine, Alder Biopharmaceuticals (ALDR), AMAG Pharmaceuticals (AMAG), DBV Technologies (DBVT), Immunomedics (IMMU), Ignyta (RXDX), Karyopharm (KPTI), RA Pharmaceuticals (RARX), TherapeuticsMD (TXMD) and Xenon Pharmaceuticals (XENE).
02/22/17
JMPS
02/22/17
INITIATION
JMPS
Outperform
Aevi Genomics Medicine coverage assumed with an Outperform at JMP Securities
JMP Securities analyst Jason Butler assumed coverage of Aevi Genomics Medicine with an $8 price target and an Outperform rating.
03/20/17
PIPR
03/20/17
NO CHANGE
Target $7
PIPR
Overweight
Aevi Genomics Medicine price target lowered to $7 from $14 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target on Aevi Genomics Medicine to $7 from $14 after the company announced that a trial of AEVI-001 in adolescents with ADHD did not meet the primary endpoint of the study. However, the Phase 3 trial showed a numerical improvement on the primary endpoint and a pre-specified sub-group analysis showed 30% or greater ADHD-RS-5 improvement, which he believes shows activity of AEVI-001. The analyst, who expects Aevi to conduct a longer Phase 2 study in younger patients at higher doses, pushed out his expectation for AEVI-001 approval by one year to 2021 and keeps an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

FORR

Forrester

$41.60

0.15 (0.36%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Earnings
Forrester reports Q2 pro forma EPS 42c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CAPL

CrossAmerica

$28.05

-0.62 (-2.16%)

16:26
07/26/17
07/26
16:26
07/26/17
16:26
Hot Stocks
CrossAmerica increases quarterly distribution 0.8% »

CrossAmerica Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Kirby sees Q3 EPS 40c-55c, consensus 56c »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Breaking Earnings news story on Mindbody »

Mindbody sees Q3 revenue …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OTEX

OpenText

$34.42

1.08 (3.24%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Hot Stocks
OpenText closes acquisition of Covisint for $103M »

OpenText announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

GGG

Graco

$105.91

-1.86 (-1.73%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Graco raising FY17 sales growth view to mid-to-high single digits »

Prior outlook was mid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 25

    Sep

MLNX

Mellanox

$44.75

-0.55 (-1.21%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Mellanox sees Q3 revenue $222M-$232M, consensus $233.61M »

Sees Q3 adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

TYL

Tyler Technologies

$181.33

0.32 (0.18%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Tyler Technologies reports Q2 EPS 91c, consensus 94c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

  • 05

    Sep

JAZZ

Jazz Pharmaceuticals

$161.52

0.27 (0.17%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Hot Stocks
Jazz enters into license agreement with XL-protein for PASylation Technology »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KEX

Kirby

$65.20

-0.2 (-0.31%)

16:25
07/26/17
07/26
16:25
07/26/17
16:25
Earnings
Kirby reports Q2 EPS 48c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

MLNX

Mellanox

$44.75

-0.55 (-1.21%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Mellanox reports Q2 EPS adjusted EPS 44c, consensus 44c »

Reports Q2 revenue $212M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

FFNW

First Financial Northwest

$16.49

0.08 (0.49%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Breaking Earnings news story on First Financial Northwest »

First Financial Northwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

GGG

Graco

$105.91

-1.86 (-1.73%)

16:24
07/26/17
07/26
16:24
07/26/17
16:24
Earnings
Graco reports Q2 EPS $1.38 with items, consensus $1.06 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 25

    Sep

LPSN

LivePerson

$11.40

-0.05 (-0.44%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
LivePerson narrows FY17 adjusted EPS view to 7c-11c from 7c-12c »

Consensus is for FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

MB

Mindbody

$26.10

-0.05 (-0.19%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Mindbody reports Q2 EPS (5c), consensus (5c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

EW

Edwards Lifesciences

$115.61

-0.26 (-0.22%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Technical Analysis
Technical View: Edwards Lifesciences spikes after results in extended session »

Shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 15

    Aug

  • 21

    Aug

BPFH

Boston Private Financial

$15.10

-0.25 (-1.63%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Boston Private Financial reports Q2 EPS 27c, consensus 22c »

Average Total Deposits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

ACGL

Arch Capital

$99.03

-0.09 (-0.09%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Arch Capital reports Q2 EPS $1.25, consensus $1.20 »

Gross premiums written by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

EW

Edwards Lifesciences

$115.61

-0.26 (-0.22%)

16:23
07/26/17
07/26
16:23
07/26/17
16:23
Earnings
Edwards Lifesciences sees Q3 adjusted EPS 80c-90c, consensus 83c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 15

    Aug

  • 21

    Aug

EW

Edwards Lifesciences

$115.69

-0.31 (-0.27%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
Edwards raises 2017 adjusted EPS outlook to $3.65-$3.85 from $3.43-3.55 »

Consensus $3.53. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 15

    Aug

  • 21

    Aug

XLNX

Xilinx

$65.32

0.86 (1.33%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
Xilinx sees Q2 revenue approximately $605M-$635M consensus $616.1M »

Q2 gross margin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 29

    Aug

LPSN

LivePerson

$11.40

-0.05 (-0.44%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
LivePerson sees Q3 adjusted EPS 4c-6c, consensus 6c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

LRCX

Lam Research

$168.34

3.88 (2.36%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
Lam Research sees Q1 EPS $3.25, +/- 12c, consensus $2.76 »

Sees Q1 revenue $2.45B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FWRD

Forward Air

$53.70

-0.72 (-1.32%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
Forward Air sees Q3 EPS 56c-60c, consensus 60c »

CFO Michael Morris said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 30

    Aug

RCII

Rent-A-Center

$12.78

0.07 (0.55%)

16:22
07/26/17
07/26
16:22
07/26/17
16:22
Earnings
Rent-A-Center reports Q2 EPS ex-items (1c), consensus 6c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.